Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF

• Authors: Jessica B Spencer, Emory University; Aimee S Browne, Emory University; Susannah D Copland, Duke University; Donna R Session, Emory University
• Journal Title: Reproductive Biology and Endocrinology
• Volume: Volume 8, Number 29
• Publisher: BioMed Central | 2010
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1186/1477-7827-8-29
• Subjects: Health Sciences, Obstetrics and Gynecology; Health Sciences, Human Development

Abstract

Background Administration of recombinant luteinizing hormone (rLH) in controlled ovarian hyperstimulation may benefit a subpopulation of patients. However, late follicular phase administration of high doses of rLH may also reduce the size of the follicular cohort and promote monofollicular development. Methods To determine if rLH in late follicular development had a negative impact on follicular growth and oocyte yield, IVF patients in our practice who received rFSH and rLH for the entire stimulation were retrospectively compared with those that had the rLH discontinued at least two days prior to hCG trigger. Results The two groups had similar baseline characteristics before stimulation with respect to age, FSH level and antral follicle count. However, the group which had the rLH discontinued at least two days prior to their hCG shot, had a significantly higher number of oocytes retrieved, including a higher number of MII oocytes and number of 2PN embryos. Conclusions When using rLH for controlled ovarian hyperstimulation, administering it from the start of stimulation and stopping it in the late follicular phase, at least two days prior to hCG trigger, may increase oocyte and embryo yield.